Invitrogen Corporation, has launched its NCode™ Human and Mouse non-coding RNA microarray. The product is the first high-density microarray that will be used for the purpose of profiling non-coding RNAs. The same array consists of both messenger RNA and non-coding RNA content. Designed by Invitrogen, these arrays are manufactured by Agilent Technologies Inc., with the use of its proprietary SurePrint technology.

According to a new study published in the Journal of the American Society of Nephrology, Oxalobacter formigenes, a naturally occurring bacteria, reduces recurring kidney stones in the body by about 70%. The research studied 247 patients with recurrent calcium oxalate stones in the kidney and compared these to a control group of 259 adults. The researchers collected data and observed a strong inverse association between presence of O. formigenes and kidney stones.